| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2578413 | Revista del Laboratorio Clínico | 2009 | 13 Pages |
Abstract
There is currently not enough evidence to replace new biomarkers with any of these already been recommended by the scientific societies. Also, the assays of some of them are not sufficiently rapid. A multimarker strategy must be created to take into account the existing scientific-based evidence, with the aim of improving outcomes in patients.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
David Pérez Surribas, Mari Cruz Cárdenas Fernández, Mariano Cortés Rius, MarÃa Fernández GarcÃa, Miguel GarcÃa Montes, Isabel Llompart Alabern, Teresa RodrÃguez González, Carmen Valldecabres Ortiz, José Antonio Viedma Contreras,